Discussing axSpA: Adalimumab dosing and uveitis recurrence in patients with ankylosing spondylitis
Nov 13, 2025
14:37
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the Association between adalimumab dosing interval and uveitis recurrence in patients with ankylosing spondylitis.
The IMID Forum